Document is current
Any future updates will be listed below
-
Authors
Soukar, Imad
Fisher, Robert J.
Bhagavatula, Sanjana
Collard, Marianne
Cole, Philip A.
Alani, Rhoda M.
-
Funding
Funding for this research was provided by:
Department of Defense Translational Research Award in Melanoma (W81XWH-21-1-0980)
National Institute of Health R35 (GM149229)
- License Information
-
More Information
Article History
Received: 26 November 2024
Accepted: 14 March 2025
First Online: 24 March 2025
Declarations
:
: PAC is a co-founder of Acylin Therapeutics and a consultant for Abbvie regarding p300 acetyltransferase inhibitors. He also is a co-inventor on a US patent application for corin (US patent no. 11,565,994). RMA is a co-founder of Acylin Therapeutics. All other authors have no competing interest.
